Here, after confirming upregulation of SPRY1 expression by 16 K hPRL both in vitro (in primary endothelial cells) and in vivo (in a mouse xenograft tumor model), we performed SPRY1-knockdown experiments to test the possible involvement of SPRY1 in regulating angiogenesis. Here, PRLR is linked to neoplasm.